This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.
1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors
ePostersLive by SciGen Technologies S.A. All rights reserved.
September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas
AML - 028
Acute Myeloid Leukemia (AML)
Quiet (Marrow-Failure-Predominant) Acute Leukemia Following or Concurrent With Solid Tumors: A Single-Center Case Series
INTRODUCTION
Therapy-related acute leukemias are typically associated with adverse biological features and unfavorable clinical outcomes. However, acute leukemias arising in patients with solid tumors may represent a heterogeneous spectrum with respect to timing, prior treatment exposure, and clinical presentation. Within this spectrum, some cases may present predominantly with cytopenias and low peripheral leukocyte counts, without a marked hyperproliferative peripheral blood picture.
AIM
To characterize the clinical presentation, temporal patterns, and early treatment responses of acute leukemia cases identified during follow-up at our center among patients with a current or previous solid tumor diagnosis, with particular attention to a cytopenia-dominant, low-WBC presentation.